Elsevier

Drug Discovery Today

Volume 19, Issue 9, September 2014, Pages 1498-1502
Drug Discovery Today

Review
Post screen
The emerging role of speckle-type POZ protein (SPOP) in cancer development

https://doi.org/10.1016/j.drudis.2014.07.009Get rights and content

Highlights

  • Speckle-type POZ (pox virus and zinc finger protein) protein (SPOP) is an E3 ubiquitin ligase adaptor.

  • SPOP is frequently mutated in prostate and endometrial cancers.

  • All the cancer associated SPOP mutations reported to date are clustered in the MATH domain.

  • SPOP mutations contribute to cancer development by altering the steady-state levels of cell signaling pathway components.

Speckle-type POZ (pox virus and zinc finger protein) protein (SPOP) is an E3 ubiquitin ligase adaptor protein that is frequently mutated in prostate and endometrial cancers. All the cancer-associated SPOP mutations reported to date are clustered in the meprin and TRAF (Tumor necrosis factor receptor-associated factor) homology (MATH) domain, presumably affecting substrate binding. SPOP mutations in prostate cancer are mutually exclusive with the ETS (Erythroblast transformation–specific) family gene rearrangements and define a distinct molecular subclass of prostate cancer. SPOP mutations contribute to prostate cancer development by altering the steady-state levels of key components in the androgen-signaling pathway.

Introduction

Ubiquitination is a post-translational mechanism that regulates crucial cellular processes such as cell proliferation, differentiation, transcription, apoptosis, among others [1]. In an evolutionarily conserved, highly orchestrated process an enzymatic cascade catalyzes the covalent attachment of ubiquitin, a 76-amino-acid polypeptide, to a wide array of substrate proteins. Ubiquitination can dictate several distinct fates for the substrate proteins; for example, targeting them to the proteasome for degradation or altering their subcellular localization. Briefly, ubiquitin is activated in an ATP-dependent reaction catalyzed by the E1 activating enzyme. The activated ubiquitin is then transiently carried by the E2 conjugating enzyme, which, along with the E3 ubiquitin ligase, transfers the ubiquitin to its specific substrate. The E3 ubiquitin ligases confer substrate specificity for ubiquitin ligation. Mammalian cells typically contain a few E1, 30–40 E2 and several hundred different E3 ubiquitin ligases. The complex interplay between the E1, E2 and E3 ubiquitin ligases permits an enormous number of substrates to be modified and thereby contributes toward the specificity and diversity of the ubiquitination process. The most prominent E3 ligase family is the Cullin–RING E3 ubiquitin ligase that consists of a molecular scaffold (Cullin) connecting the substrate-specific adaptor protein to a catalytic component consisting of a RING finger domain and an E2 ubiquitin conjugating enzyme. Mammalian cells express a number of Cullin scaffold proteins, for example Cullin 1, Cullin 2, Cullin 3, Cullin 4A, Cullin 4B, Cullin 5, Cullin 7 and Cullin 9 2, 3. The binding of the Cullins to their unique substrate-binding adaptor proteins provides specificity to the E3 ubiquitin ligase complex. One such substrate-binding adaptor protein that has gained increased attention owing to its far-reaching effects in cellular physiology and in pathological conditions like prostate cancer is the speckle-type POZ (pox virus and zinc finger protein) protein (SPOP).

Historically, antibodies from patients with autoimmune disorders have been crucial in the discovery of novel nuclear antigens 4, 5. For example, immunostaining of COS7 cells with the serum from a scleroderma patient revealed a unique speckled pattern in the nuclei that could not be attributed to known antigens. Further characterization revealed that the novel nuclear antigen was a part of a 374-amino-acid protein with a POZ domain [6] and a meprin and TRAF homology (MATH) domain [7]. The novel protein was named SPOP owing to its discrete speckled nuclear staining pattern and the presence of a POZ domain [6]. From an evolutionary standpoint, SPOP appears to be rather conserved; its orthologs, MEL (Maternal effect lethal)-26 in Caenorhabditis elegans and HIB (Hedgehog-induced MATH and BTB domain containing protein) in Drosophila melanogaster exhibit sequence similarity and carry out functions analogous to their mammalian counterparts 7, 8.

Section snippets

Structure of the SPOP protein

Structurally, the 42 kDa protein SPOP comprises an N-terminal MATH domain, a bric-a-brac, tramtrack and broad complex (BTB)/POZ domain, a 3-box domain and a C-terminal nuclear localization sequence (Fig. 1). The MATH domain is primarily involved in substrate recognition and binding. Substrate binding is promoted by characteristic amino acid residues Y87, F102, Y123, W131 and F133 present in the MATH domain of SPOP. In turn, the substrate proteins require the presence of a characteristic

SPOP as a regulator of cellular function

SPOP substrates are implicated in several essential cellular functions (Table 1) 16, 17, 18, 19, 20, 21, 22, 23, 24, 25. For example, death domain–associated protein (DAXX), a protein involved in transcription, cell-cycle regulation and apoptosis, is a substrate of SPOP. DAXX binds to the MATH domain of SPOP and is subsequently ubiquitinated and targeted for degradation in the proteasome 15, 19. When DAXX interacts with ETS-1, it represses the transcriptional activation of ETS-1 target genes

SPOP in human cancers

SPOP was first reported as a significantly mutated gene in human prostate cancers in a study that analyzed somatic mutations in 58 tumors [27]. Next, whole-genome sequencing of seven primary prostate tumors and matched normal tissue biopsies revealed SPOP mutations in two of the tumor samples, but none in the matched normal samples [28]. In subsequent studies, SPOP mutations were identified in 6–13% of primary prostate adenocarcinomas and 14.5% of metastatic prostate cancers 29, 30, 31. The

Functional consequences of SPOP mutations in prostate cancer

SPOP has recently been shown to be a component of the DNA damage response (DDR) machinery. SPOP depletion results in an impaired DDR and hypersensitivity to ionizing radiation [37]. The tumor suppressor role of SPOP in prostate and endometrial cancers is supported by the clustering of mutations in the MATH domain. Knockdown of SPOP using siRNA or overexpression of the F133V MATH domain variant enhanced the invasive properties of prostate cancer cells [29]. The MATH domain mutations are

Concluding remarks

SPOP is an adaptor protein that aids in the degradation of several substrates that have important roles in cellular development and physiology. SPOP mutations define a distinct molecular subclass of prostate cancer, and are also observed in endometrial cancers. Future studies should address whether SPOP mutations in prostate cancer have any association with clinical outcome and risk stratification. Further insights into the mechanistic basis of SPOP-mediated cancer development can be obtained

Conflict of interest

The author has no conflicts of interest to declare.

Acknowledgements

I apologize to those whose relevant research was not cited owing to space limitations. I thank Susmita Ramanand and Maxwell Tran for insightful comments, and Aparna Ghosh for help with figure preparation. This work was supported in part by a Young Investigator Award from the Prostate Cancer Foundation and the NIH Pathway to Independence (PI) Award (K99/R00) K99CA160640.

References (43)

  • J. An

    Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants

    Cell Rep.

    (2014)
  • G. Li

    SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer

    Cancer Cell

    (2014)
  • S.C. Baca

    Punctuated evolution of prostate cancer genomes

    Cell

    (2013)
  • V.K. Arora

    Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade

    Cell

    (2013)
  • X.E. Zhou

    Identification of SRC3/AIB1 as a preferred coactivator for hormone-activated androgen receptor

    J. Biol. Chem.

    (2010)
  • A. Hershko

    Basic Medical Research Award. The ubiquitin system

    Nat. Med.

    (2000)
  • X.H. Pei

    Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis

    Cancer Res.

    (2011)
  • M.D. Petroski et al.

    Function and regulation of cullin-RING ubiquitin ligases

    Nat. Rev. Mol. Cell Biol.

    (2005)
  • C.A. Ascoli et al.

    Identification of a novel nuclear domain

    J. Cell Biol.

    (1991)
  • L.E. Andrade

    Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin

    J. Exp. Med.

    (1991)
  • L. Xu

    BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3

    Nature

    (2003)
  • Cited by (82)

    • SPOP promotes CREB5 ubiquitination to inhibit MET signaling in liver cancer

      2024, Biochimica et Biophysica Acta - Molecular Cell Research
    View all citing articles on Scopus
    View full text